133 related articles for article (PubMed ID: 38567708)
21. Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy.
Yang XJ; Xi YM; Li ZJ
Biomed Res Int; 2019; 2019():4860268. PubMed ID: 31032347
[TBL] [Abstract][Full Text] [Related]
22. Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.
Zhang C; Li H; Jiang W; Zhang X; Li G
Oncotarget; 2016 Dec; 7(50):83755-83766. PubMed ID: 27835879
[TBL] [Abstract][Full Text] [Related]
23. Icaritin and intratumoral injection of CpG treatment synergistically promote T cell infiltration and antitumor immune response in mice.
Dongye Z; Wu X; Wen Y; Ding X; Wang C; Zhao T; Li J; Wu Y
Int Immunopharmacol; 2022 Oct; 111():109093. PubMed ID: 35930912
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
[TBL] [Abstract][Full Text] [Related]
25. Icaritin Preparation from Icariin by a Special
Wang Z; Liu C; Yu H; Wu B; Huai B; Zhuang Z; Sun C; Xu L; Jin F
J Microbiol Biotechnol; 2022 Apr; 32(4):437-446. PubMed ID: 35283431
[TBL] [Abstract][Full Text] [Related]
26. Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.
Zhu S; Wang Z; Li Z; Peng H; Luo Y; Deng M; Li R; Dai C; Xu Y; Liu S; Zhang G
Oncotarget; 2015 Apr; 6(12):10460-72. PubMed ID: 25865044
[TBL] [Abstract][Full Text] [Related]
27. A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells.
Huang X; Zhu D; Lou Y
Eur J Pharmacol; 2007 Jun; 564(1-3):26-36. PubMed ID: 17382317
[TBL] [Abstract][Full Text] [Related]
28. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of Icaritin and β-anhydroicaritin Mannich Base Derivatives and Their Cytotoxic Activities on Three Human Cancer Cell Lines.
Nguyen VS; Shi L; Wang SC; Wang QA
Anticancer Agents Med Chem; 2017; 17(1):137-142. PubMed ID: 27039924
[TBL] [Abstract][Full Text] [Related]
30. Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings.
Zhu Jf; Li Zj; Zhang Gs; Meng K; Kuang Wy; Li J; Zhou Xf; Li Rj; Peng Hl; Dai Cw; Shen JK; Gong Fj; Xu Yx; Liu Sf
PLoS One; 2011; 6(8):e23720. PubMed ID: 21887305
[TBL] [Abstract][Full Text] [Related]
31. Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib.
Yang Y; Sun M; Yao W; Wang F; Li X; Wang W; Li J; Gao Z; Qiu L; You R; Yang C; Ba Q; Wang H
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32179631
[TBL] [Abstract][Full Text] [Related]
32. A comparative study on the
Li H; Li Y; Ao H; Fu J; Guo Y; Han M; Yan X; Chen X; Wang X
Drug Deliv; 2020 Dec; 27(1):1176-1187. PubMed ID: 32762483
[TBL] [Abstract][Full Text] [Related]
33. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
[TBL] [Abstract][Full Text] [Related]
34. An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells.
Guo Y; Zhang X; Meng J; Wang ZY
Eur J Pharmacol; 2011 May; 658(2-3):114-22. PubMed ID: 21376032
[TBL] [Abstract][Full Text] [Related]
35. IGF-1 receptor is involved in the regulatory effects of icariin and icaritin in astrocytes under basal conditions and after an inflammatory challenge.
Zhang WD; Li N; Du ZR; Zhang M; Chen S; Chen WF
Eur J Pharmacol; 2021 Sep; 906():174269. PubMed ID: 34147477
[TBL] [Abstract][Full Text] [Related]
36. Synergistic anticancer effect of flavonoids from Sophora alopecuroides with Sorafenib against hepatocellular carcinoma.
Zhu XF; Sun ZL; Ma J; Hu B; Yu MC; Liu XJ; Yang P; Xu Y; Ju D; Mu Q
Phytother Res; 2023 Feb; 37(2):592-610. PubMed ID: 36180975
[TBL] [Abstract][Full Text] [Related]
37. Icaritin induces ovarian cancer cell apoptosis through activation of p53 and inhibition of Akt/mTOR pathway.
Gao L; Chen M; Ouyang Y; Li R; Zhang X; Gao X; Lin S; Wang X
Life Sci; 2018 Jun; 202():188-194. PubMed ID: 29625193
[TBL] [Abstract][Full Text] [Related]
38. Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling.
Yang JG; Lu R; Ye XJ; Zhang J; Tan YQ; Zhou G
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085115
[TBL] [Abstract][Full Text] [Related]
39. Icaritin induces mitochondrial apoptosis by up-regulating miR-124 in human oral squamous cell carcinoma cells.
Jin L; Miao J; Liu Y; Li X; Jie Y; Niu Q; Han X
Biomed Pharmacother; 2017 Jan; 85():287-295. PubMed ID: 27889233
[TBL] [Abstract][Full Text] [Related]
40. Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signalling.
Xu B; Jiang C; Han H; Liu H; Tang M; Liu L; Ji W; Lu X; Yang X; Zhang Y; Liu Y
Clin Exp Pharmacol Physiol; 2015 Dec; 42(12):1296-307. PubMed ID: 26356761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
